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Abstract
Background: Understanding genetic determinants of a microbial phenotype generally involves creating and
comparing isogenic strains differing at the locus of interest, but the naturally existing genomic and phenotypic
diversity of microbial populations has rarely been exploited. Here we report use of a diverse collection of 616
carriage isolates of Streptococcus pneumoniae and their genome sequences to help identify a novel determinant of
pneumococcal colonization.
Results: A spontaneously arising laboratory variant (SpnYL101) of a capsule-switched TIGR4 strain (TIGR4:19F) showed
reduced ability to establish mouse nasal colonization and lower resistance to non-opsonic neutrophil-mediated
killing in vitro, a phenotype correlated with in vivo success. Whole genome sequencing revealed 5 single nucleotide
polymorphisms (SNPs) affecting 4 genes in SpnYL101 relative to its ancestor. To evaluate the effect of variation in each
gene, we performed an in silico screen of 616 previously published genome sequences to identify pairs of closely-
related, serotype-matched isolates that differ at the gene of interest, and compared their resistance to neutrophil-killing.
This method allowed rapid examination of multiple candidate genes and found phenotypic differences apparently
associated with variation in SP_1645, a RelA/ SpoT homolog (RSH) involved in the stringent response. To establish
causality, the alleles corresponding to SP_1645 were switched between the TIGR4:19F and SpnYL101. The wild-type
SP_1645 conferred higher resistance to neutrophil-killing and competitiveness in mouse colonization. Using a similar
strategy, variation in another RSH gene (TIGR4 locus tag SP_1097) was found to alter resistance to neutrophil-killing.
Conclusions: These results indicate that analysis of naturally existing genomic diversity complements traditional
genetics approaches to accelerate genotype-phenotype analysis.
Keywords: Genomic diversity, Pneumococcal colonization, RelA/ SpoT homolog
Background
A general question in microbiology is to understand the
genetic determinants underlying a microbial phenotype,
such as increased virulence or transmissibility. Develop-
ments in sequencing technology now allow rapid identifica-
tion of genetic differences among phenotypic variants, but
it remains a time-consuming process to verify the function
of each genetic variation by constructing isogenic strains
(chimeras) in which only one gene of interest differs. Gen-
omic diversity of existing microbial populations can be
used to infer the consequences of polymorphisms by evalu-
ating phenotypic differences between naturally occurring
variants, if 1) the naturally occurring variants harbor the
genetic variation of interest and 2) other known genetic de-
terminants of the phenotypic difference can be accounted
for. Testing existing variants can reduce the amount of
time and resources spent on constructing isogenic strains,
so we hypothesized that using naturally occurring genomic
diversity can accelerate gene function discovery.
Streptococcus pneumoniae (pneumococcus) is an import-
ant human pathogen that causes pneumonia, meningitis,
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sinusitis and otitis media worldwide. Pneumococcus fre-
quently colonizes the human nasopharynx, which precedes
invasive infections, and these colonization events serve as
the reservoir for bacterial transmission [1]. There are more
than 90 capsular serotypes of pneumococcus. Simultan-
eous colonization by multiple serotypes and competition
between serotypes has been documented during nasopha-
ryngeal carriage in humans [1,2]. Understanding the factors
that determine serotype patterns of carriage is an import-
ant public health issue [3,4]. The capsule itself has a major
impact on carriage: studies have shown that serotype con-
trols resistance to surface killing mediated by human neu-
trophils [4], ability to compete against co-colonizing strains
in a mouse model of multiple-strain carriage [Krzysztof
Trzciński et al., unpublished data], and pneumococcal cell
surface charge [5]. All the three properties, in turn, are cor-
related with carriage prevalence in human populations
[4,5]. For genetic variations outside the capsular polysac-
charide synthesis (cps) region, much less is known about
their contribution to resistance to surface killing or ability
to compete during nasopharyngeal colonization.
Here we report an approach (Figure 1) that uses existing
genomic diversity within a collection of carriage isolates,
for which draft genomes are available, to accelerate the
discovery of a novel, non-capsule genetic determinant of
pneumococcal colonization. The project began during an
experimental study of competitive colonization of mice by
different strains of pneumococci, which had been con-
structed such that they were all of the TIGR4 genetic back-
ground but differed at the cps locus, which determines
serotype. A spontaneous variant of one of these strains,
TIGR4:19F (hereafter the variant is called SpnYL101),
showed an unexpected but repeatable change of pheno-
type, specifically a reduced ability to colonize a mouse in
the presence of competing strains, relative to the parental
strain. We sequenced the whole genomes of the parental
strain and the variant and identified 5 single nucleotide
polymorphisms (SNPs) separating them. To improve the
efficiency of the effort to identify which of these SNPs had
caused the phenotypic change, we set out to evaluate the
effect of sequence variation in genes that are affected by
the SNPs by testing a related phenotype in pairs of isolates
selected from a genomically sequenced collection of
pneumococci carried by children in Massachusetts. For
each candidate gene, we sought pairs of isolates from the
sequenced collection that (1) were serotype-matched,
because serotype is a known determinant of competitive
colonization; (2) diverged substantially at the candidate
gene, and (3) were otherwise as similar genetically as pos-
sible. We hypothesized that within an isolate pair selected
by these criteria, phenotypic differences could be reason-
ably attributed to sequence variations in the gene that dif-
fered substantially. After examining three such pairs, we
found evidence supporting the role of variation in gene
SP_1645, a RelA/SpoT homolog (RSH) protein involved in
the stringent response (SR). The SR globally regulates bac-
terial transcription, translation and replication in response
to nutrient limitation and other stresses [6]. The RSH pro-
teins in Gram-positive bacteria catalyze the synthesis and
degradation of guanosine tetraphosphate (ppGpp), which
is a critical mediator of the stringent response [7]. The
RelA homolog protein in pneumococcus (encoded by
relspn) was previously shown to modulate pneumococcal
disease severity and course of progression in a mouse
model of infection [8]. We confirmed the effect of the
SP_1645:T1019C variation, one of the 5 SNPs separating
TIGR4:19F and SpnYL101, by evaluating the phenotypes
in strains in which the SP_1645 alleles were exchanged.
Using a similar strategy, we found that variation in another
RSH gene (SP_1097) contributes to change in resistance to
neutrophil-killing. As collections of bacterial whole gen-
ome sequence data become larger, they will provide an in-
creasingly valuable resource for targeting candidate genetic
changes that cause phenotypic changes of interest.
Results
A variant of pneumococcus with reduced fitness
We observed a variant of the TIGR4:19F strain (SpnYL101)
showing reduced ability to compete against other strains
during nasal colonization, compared to the originally con-
structed TIGR4:19F (Figure 2A). When co-colonizing
A pair of natural isolates for each target gene:  
    Serotype Matched 
    Closely related 
    Allele sequences differ substantially 
Phenotypic evaluation of the natural isolates pair 
Phenotypic difference 
Target genes 
(non-synonymous changes) 
No phenotypic difference 
A likely causal gene An improbable causal gene 
Confirm gene Function 
Phenotypic difference between strains 
whole-genome sequencing 
Figure 1 A diagram summarizing the approach to use naturally
existing variants in combination with sequencing of laboratory
variants to accelerate the discovery of genetic variation underlying
phenotypes of interest
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C57BL/6 mice together with 5 other strains (TIGR4:1,
TIGR4:4, TIGR4:14, TIGR4:19A, and TIGR4:23F), the
SpnYL101 strain showed significantly lower competitive
index on day 1 (median = −0.63) than did the originally
constructed TIGR4:19F strain (median = 0.42; Mann–
Whitney test, U = 11.00, n1 = 15, n2 = 5, p = 0.023). By day
7, the competitive index of the SpnYL101 strain was close
to the lower limit of detection (median = −3.00), which
was significantly lower than the competitive index of the
TIGR4:19F strain (median = −0.55; Mann–Whitney test,
U = 24.00, n1 = 14, n2 = 7, p = 0.043). The results indicate
that the SpnYL101 strain is less likely to establish carriage
in mice than the TIGR4:19F strain in the presence of co-
colonizers.
It has been reported that higher carriage prevalence of
S. pneumoniae in human populations is associated with
higher resistance to neutrophil-killing [4]. We therefore
tested whether the SpnYL101 strain is more likely to be
killed by neutrophils than the TIGR4:19F strain in a surface
killing assay [4]. As shown in Figure 2B, the survival of the
SpnYL101 strain (mean = 0.39, SD = 0.084) was signifi-
cantly lower than that of the TIGR4:19F strain (mean =
0.60, SD = 0.11; t-test, t(16) = −5.28, p < 0.0001).
Decreased degree of encapsulation was shown to reduce
S. pneumoniae resistance to non-opsonic neutrophil-
mediated killing [4]. We therefore assessed whether the
SpnYL101 strain exhibited reduced capsule production
compared to TIGR4:19F. Both strains were confirmed to
remain serotype 19 F by Pneumotest-latex serotyping. The
cell-associated type 19 F capsular polysaccharide was quan-
tified by an inhibition ELISA assay, and no evidence of re-
duction in capsule production was observed for SpnYL101
(Figure 2C). Furthermore, SpnYL101 and TIGR4:19F
showed similar efficiency in colonizing C57BL/6 mice in
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Figure 2 A variant of the TIGR4:19F strain, SpnYL101, showed impaired colonization in a mouse model of multi-strain nasopharyngeal carriage and
lower resistance to surface phagocytosis in vitro. (A) In a mouse colonization model, five TIGR4 capsular variants (TIGR4:1, TIGR4:4, TIGR4:14, TIGR4:19A,
TIGR4:23F) were mixed with either TIGR4:19F (solid circle) or SpnYL101 (open circle) at equal amount (~106 CFU each) and were used to intranasally
challenge C57BL/6 mice. Nasal wash samples were obtained on days 1 and 7 post challenge, and the frequency of the serotype 19 F variant in each
sample was determined by qPCR. The competitive index of the TIGR4:19F or SpnYL101 in each sample is shown. Horizontal bars are medians. p-values
are derived from Mann–Whitney tests. (B) Survival rate of the TIGR4:19F and the SpnYL101 measured in a non-opsonic neutrophil-mediated killing
assay. Error bars represent SEM. The p-value is derived from t-test (n = 10 for each group). (C) Cell-associated type 19 F capsular polysaccharide (Ps)
measured by an inhibition ELISA assay. Error bars represent SEM from two independent experiments. The p-value is derived from t-test. (D) Single-
strain colonization of C57BL/6 mice by either TIGR4:19F or SpnYL101. Colonization densities as measured by total CFU/nasal wash on day 1 and day 4
are shown. Horizontal bars are medians. p-values are derived from Mann–Whitney tests.
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single-strain colonization experiment (Figure 2D). Thus,
the SpnYL101 strain appeared to have acquired non-
capsule change(s) that can affect both competition during
co-colonization and resistance to surface phagocytosis. We
measured the in vitro growth rates of SpnYL101 and
TIGR4:19F in THY, and no statistically significant differ-
ence was observed (Additional file 1: Figure S1).
Genetic Variations identified in the SpnYL101 strain
We hypothesized that the phenotypic differences between
the SpnYL101 and the TIGR4:19F strains were caused by
genetic variation. To test this hypothesis, we sequenced
the whole genome of the two strains using the Illumina
MiSeq system and compared the two genomes to identify
SNPs distinguishing the two strains.
Five SNP sites were identified between the SpnYL101
and the TIGR4:19F genomes (Table 1). Four SNP sites were
located in coding sequences (CDS) and the other one was
located in an intergenic region. Four genes, with TIGR4
locus tags SP_0152, SP_0655, SP_1119, and SP_1645, were
affected by the four SNPs located in CDS, respectively.
Consistent with our serotyping result, no SNPs were lo-
cated in the cps locus that is responsible for capsular poly-
saccharide synthesis. In the SP_0655 locus, the SNP did
not alter the amino acid sequence encoded (synonymous
SNP), and therefore it was not likely to cause a phenotypic
difference. In contrast, in the SP_0152, SP_1119, and
SP_1645 loci, the SNP caused a change in the translated
amino acid sequence (non-synonymous SNP). These three
single-nucleotide variations might explain the differing
phenotypes of the TIGR4:19F and SpnYL101 strains.
Testing the effects of SNP with naturally existing diversity
To test whether variation in a candidate gene causes a
phenotypic difference, classical genetic approaches in-
volve creating a set of isogenic strains in which only the
candidate gene differs and evaluating phenotypes among
the set of isogenic strains. If multiple candidate genes
were to be examined, multiple sets of isogenic strains
would usually need to be constructed.
We sought to accelerate this process using a diverse
collection of nasopharyngeal carriage isolates for which
draft whole-genome sequences have previously been ob-
tained [9]. We first examined whether genes affected by
the non-synonymous SNPs between the SpnYL101 and
the TIGR4:19F also vary in the carriage isolates. Se-
quence variation was found for all the three genes af-
fected by non-synonymous SNPs (Figure 3A). For each
target gene, we identified a pair of serotype-matched,
closely-related isolates that differed substantially at the
target gene (Figure 3A, see Materials and Method for
identification protocol). Thus, each pair of carriage iso-
lates mimicked a set of quasi-“isogenic” strains and was
subsequently tested in the surface killing assay. Com-
paratively little variation was found around the rest of
the genome (Additional file 1: Table S1). As shown in
Figure 3B, no significant difference in resistance to
neutrophil-killing was found between isolates 291880
and ND6135 (designed to test effects of sequence vari-
ation in SP_0152; t-test, t(18) = 1.30, p =0.21) or between
isolates 342672 and LE4007 (designed to test effects of se-
quence variation in SP_1119; t-test, t(18) = 1.29, p =0.22).
In contrast, a significant difference in resistance to
neutrophil-killing was found between isolates R34-3067
and GL3049 (designed to test effects of sequence vari-
ation in SP_1645; t-test, t(18) = 2.82, p =0.011). A whole
genome alignment of this pair found only 28 sites at
which these two isolates had different bases [9]. These
results suggested that the SP_1645 variation might be a
non-capsule determinant of resistance to neutrophil-
killing.
The SP_1645 C1019T variation in SpnYL101 contributes
to its defects
To confirm whether the SP_1645:C1019T variation in
SpnYL101 decreases the resistance to neutrophil-killing
in vitro, we first replaced the SP_1645 locus in both the
TIGR4:19F and the SpnYL101 by a Janus cassette to
knock out the gene function. Unlike the parental strains,
the SP_1645-knock out strains showed no significant
Table 1 SNPs identified between TIGR4:19F and SpnYL101
Positiona TIGR4:19F SpnYL101 CDS Codonb SNP Namec
150259 A C SP_0152 N SP_0152:C380A
626569 C T SP_0655 S SP_0655:C906T
1052463 A G SP_1119 N SP_1119:G652A
1542955 G A SP_1645 N SP_1645:C1019T
1543998 G A - I A1543998G
aPosition corresponds to reference TIGR4 genome sequence (GenBank accession: AE005672).
bIndicator of the effect of the single nucleotide difference: non-synonymous codon change (N), synonymous codon change (S), or change in the inter-gene
region (I).
cSNP located in a CDS is named according to the CDS name. After the CDS name, the first letter is the nucleotide sequence in the coding strand of the TIGR4
genome; the number represents the nucleotide location within the CDS; and the second letter represents the alternative nucleotide sequence. SNP located in the
inter-gene region is named by a letter (nucleotide sequence in the TIGR4 genome), followed by a number (the SNP position) and another letter (the alternative
nucleotide sequence).
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difference in survival from neutrophil-killing (Figure 4A,
middle two bars, t(17) = 1.15, p = 0.27). The results sug-
gested that the SP_1645 gene is necessary for this pheno-
typic difference between TIGR4:19F and SpnYL101.
Subsequently, we switched the alleles the SP_1645 locus
between the TIGR4:19F and the SpnYL101 strains by
transforming the SP_1645-knock out strains of TIGR4:19F
and SpnYL101 with alleles amplified from the SP_1645
locus of SpnYL101 and TIGR4:19F, respectively. The
resulting two strains, SpnYL104 and SpnYL105, were sub-
jected to the surface killing assay (Figure 4A, right two
bars). The survival of SpnYL104 (mean = 0.61 S.D. =0.14)
was significantly lower than that of SpnYL105 (mean =
0.76, S.D. = 0.08; t(14) = 3.21, p = 0.0064). The results indi-
cated that the allele in the SP_1645 locus of the SpnYL101
strain is sufficient to confer reduced resistance to
neutrophil-killing in vitro.
Since the SP_1645 SNP caused a change in resistance to
neutrophil-killing, we hypothesized that the SP_1645:C1019T
variation also contributes to the ability to establish nasal
colonization. To test this hypothesis, a reference strain
(TIGR4:19A) was mixed with either SpnYL104 or
SpnYL105 at equal ratio and the mixtures were used to in-
tranasally challenge C57BL/6 mice. Nasal wash samples
were collected on days 1, 4, and 7 post-challenge, and the
competitive index was measured as described in Materials
and Methods. The SpnYL104 and the SpnYL105 showed
similar competitive index on day 1 (Figure 4B, Mann–
Whitney test, U = 30.00, n1 = 9, n2 = 10, p = 0.24). By day
4, the SpnYL105 strain showed a slightly higher competi-
tive index (median = 0.86) than was observed for the
SpnYL104 (median = −0.17) and the difference was signifi-
cant (Mann–Whitney test, U = 6.00, n1 = 7, n2 = 6, p =
0.035). By day 7 of colonization, the competitive index for
the SpnYL105 strain (median = 0.94) was significantly
higher than that of the SpnYL104 strain (median = −1.63,
Mann–Whitney test, U = 3, n1 = 9, n2 = 7, p = 0.003). The
results indicated that the SP_1645:C1019T variation is an
important determinant of pneumococcal competitiveness
during nasal colonization in the mouse.
Effects of variation in other genes involved in the
stringent response pathway
The SP_1645 gene product belongs to the RelA/SpoT
homolog proteins mediating the stringent response (SR).
It is of interest to understand the role of the pneumococ-
cal SR pathway in colonization success. We hypothesized
that naturally existing genomic diversity can provide in-
formation on the effects of variation in other SR genes.
Three putative pneumococcal SR genes (TIGR4 locus tag
SP_1967, SP_1073, and SP_1097) were identified accord-
ing to the KEGG Orthology database (K07177, K03086,
A
B
Figure 3 Evidence for the effects of variable genes between TIGR4:19F and SpnYL101 in carriage isolates. (A) For each gene that contained a
non-synonymous substitution between TIGR4:19F and SpnYL101, we identified a pair of carriage isolates that are serotype-matched, closely
related, but differ substantially in the target gene alleles, such that phenotypic differences within the pair could be reasonably attributed to allelic
variations in the target gene. (B) The carriage isolates were subjected to the non-opsonic neutrophil-mediated killing assay. Mean survival rates
are shown (n = 10 for each strain). Error bars represent SEM. The p-values were derived from t-tests.
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and K07816, respectively). For each putative SR gene, we
identified a pair of serotype-matched, closely-related iso-
lates that differ substantially at the target gene (Figure 5A)
and evaluated their survival from surface phagocytosis
(Figure 5B). No significant difference in survival from sur-
face phagocytosis was found between isolates LE4038 and
LE4047 (designed to test effects of sequence variation in
the gene with TIGR4 locus tag SP_01967; t-test, t(18) =
0.23, p = 0.82). In contrast, a significant difference in re-
sistance to neutrophil-killing was found between isolates
146066 and 372297 (designed to test effects of sequence
variation in SP_1073; t-test, t(18) = 4.90, p =0.0001) and
between isolates 135771 and ND6022 (designed to test ef-
fects of sequence variation in SP_1097; t-test, t(18) = 5.21,
p < 0.0001). The results suggested that variation in specific
stringent response genes was associated with change in re-
sistance to neutrophil-killing.
SP_1097 is the only other gene in the TIGR4 genome that
encodes a putative GTP pyrophosphokinase [EC:2.7.6.5]
in addition to SP_1645. GTP pyrophosphokinase activity
could influence the level of guanosine tetraphosphate
(ppGpp), which is the upstream mediator of SR and con-
trols other downstream SR effectors. We therefore wanted
to test whether the difference between alleles corresponding
to SP_1097 in 135771 and ND6022 (only one non-
synonymous SNP) causes changes in resistance to
neutrophil-killing. We constructed two isogenic strains,
SpnYL106 and SpnYL107 (Figure 6A), in which the
SP_1097 locus in the TIGR4:6B was replaced by alleles cor-
responding to SP_1097 in 135771 and ND6022, respect-
ively. Consistent with what was observed for carriage
isolates 135771 and ND6022, the SpnYL106 showed a sig-
nificantly higher survival than the SpnYL107 (Figure 6B; t-
test, t(18) = 2.38, p =0.029). We also estimated the in vitro
growth rate for both strains by fitting growth curves to an
exponential growth equation. The SpnYL106 showed a sig-
nificantly higher in vitro growth rate than the SpnYL107
(Figure 6C; t-test, t(14) = 20.3, p <0.0001). To test whether
the SP_1097 SNP influences colonization in vivo, the com-
petitive indexes of SpnYL106 and SpnYL107 were mea-
sured as described in Materials and Methods. Among mice
that remained detectably colonized by at least one strain,
SpnYL106 and SpnYL107 showed similar competitive in-
dexes on both day 1 and day 4 (Additional file 1: Figure S2).
Discussion
In this study, we observed phenotypic differences between
the TIGR4:19F and SpnYL101 strains. We sequenced the
A
B
Figure 4 The SP_1645:C1019T variation leads to lower resistance to surface phagocytosis in vitro and impaired competitiveness in vivo. (A) The
TIGR4:19F strain exhibited higher resistance to neutrophil-mediated killing than the SpnYL101 strain (left two bars). The SP_1645 gene was
replaced by a Janus cassette in the TIGR4:19F and the SpnYL101, and the resulting SP_1645- knock out strains showed no significant difference in
resistance to neutrophil-killing (middle two bars). The TIGR4:19F strain carrying SP_1645 1019 T allele (SpnYL104) was less resistant to neutrophil-
killing than did the SpnYL101 strain carrying the SP_1645 1019C allele (SpnYL105, right two bars). Error bars represent SEM. The
p-values were derived from t-tests (n = 10 for each group). (B) Competitive index of the SpnYL104 (open circles) and the SpnYL105 (solid circles)
relative to a capsular variant of the TIGR4 (TIGR4:19A) as the reference strain. Data on days 1, 4 and 7 post-challenge are shown. The horizontal
bars are medians. p-values are derived from Mann–Whitney tests.
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AB
Figure 5 Evidence for variation of specific stringent response genes associated with change in resistance to neutrophil-killing. (A) Pneumococcal
genes assumed to be involved in the stringent response pathway were identified by searching the KEGG Orthology groups that contain stringent
response genes in E.coli (K07177, K03086, and K07816). To test the effects of sequence variation in a target gene, a pair of pneumococcal carriage
isolates that are serotype-matched, closely related, but differ substantially at the target gene were identified. (B) The carriage isolates were
subjected to the non-opsonic neutrophil-mediated killing assay. Mean survival rates are shown (n = 10 for each strain). Error bars represent SEM.
The p-values were derived from t-tests.
A
B C
Figure 6 Mutation in SP_1097 results in higher resistance to surface phagocytosis and higher growth rate in vitro. (A) The SP_1097 locus in the
TIGR4:6B strain was replaced by a kanamycin resistance marker (Kan) fused to the allele corresponding to SP_1097 from either strain 135771 or
strain ND6022 to construct the SpnYL106 and SpnYL107 strains, respectively. The vertical black bar indicates the only SNP between the two
alleles (C for 135771 and T for ND6022 at position 170). (B) Survival rate of the SpnYL106 and the SpnYL107 strains measured in a non-opsonic
neutrophil-mediated killing assay. Error bars represent SEM. The p-value is derived from t-test (n = 10 for each group). (C) Growth rate of the
SpnYL106 and the SpnYL107 strains. The strains were cultured in THY medium at 37°C and the increase in O.D. 620 was measured for 6 hours.
The increase in O.D. was fitted to an exponential growth to estimate the growth rate. Error bars represent SEM. The p-value is derived from t-test
(n = 12 for each group).
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whole genomes of the two strains and identified 5 SNPs as
the candidate causes of the phenotypic differences. Subse-
quently, we prioritized hypotheses about the likely roles of
genetic variation in genes affected by a SNP by testing a
pair of serotype-matched, closely-related carriage isolates
that differs substantially at each candidate gene. Such iso-
late pairs were identified by genomic analysis of a large
collection of carriage isolates with diverse genetic back-
ground and evidence was found to support the phenotypic
impact of variation in the gene with TIGR4 locus tag
SP_1645. Although it would be ideal to compare closely-
related isolate pairs that harbor the exact same SNP of
interest, such pairs may not always be available for a given
collection (Additional file 1: Table S2). Additionally, this
method aims to make the best use of the available gen-
omic diversity information to complement (not replace)
traditional genetics approaches and accelerate genotype-
phenotype analysis. It could be inappropriate if the dis-
tance between the most closely related strains happens to
be quite large because more genomic changes would make
it difficult to evaluate the contribution from a specific
gene variation. We also acknowlodge that serotype match-
ing may not be as informative for other studies. As each
pair of isolates came from the same ‘sequence cluster’,
there is unlikely to be much relevant accessory genome
variation distinguishing them [10], making it unlikely that
the differences in phenotypes are down to other genetic
variation, althogh such differences cannot be formally
ruled out. We therefore emphasize that the method is
complementary to, rather than a direct replacement for,
experimental work that can identify the causal genetic
variant underlying phenotypic differences. Finally, we con-
firmed the effects of the SP_1645:C1019T variation by
using laboratory-constructed isogenic strains. Notably, the
TIGR4:19F and SpnYL101 strains became similarly sus-
ceptible to neutrophil-killing when the SP_1645 locus was
knocked out from both strains (Figure 4A). This result
indicated that the other 4 SNPs were unlikely to play a
major role in resistance to neutrophil-killing.
Little is known about the cellular function of the
SP_1645:C1019T variation we identified. When the
SP_1645 locus in the TIGR4:19F strain was replaced by
the Janus cassette, no significant change in resistance to
neutrophil-killing was observed. This is consistent with re-
sults in a previous transposon mutagenesis study [11], also
using variants of TIGR4 (presumably with the wild-type al-
lele), that disruption of the SP_1645 locus by transposon
insertions did not cause a detectable defect in pneumococ-
cal colonization of mouse nasopharynx. In contrast, re-
placing the SP_1645 locus in the SpnYL101 strain by Janus
cassette significantly increased resistance to neutrophil-
killing, restoring it to a level similar to that seen in the
TIGR4:19F strain. This observation suggested that the
SP_1645 allele in SpnYL101 could represent a gain-of-
function change in which the gained function appeared to
associate with reduced resistance to surface killing. Since it
has been shown that surface charge of pneumococcus in-
fluences its resistance to neutrophil-killing [5], we mea-
sured the zeta potential of the TIGR4:19F, SpnYL101, and
the SP_1645 knock-out strains, and did not find a signifi-
cant difference in surface charge among them. In addition, the
protein encoded by the SP_1645 gene was not in a previously
reported list of human antibody antigens [12] or a list of
human TH-17 cell antigens [13]. Thus, the SP_1645:C1019T
variation could represent a previously unknown determinant
that, directly or indirectly, influences the interaction between
pneumococcus and neutrophils.
The gene with TIGR4 locus tag SP_1645 is inferred to
encode a RelA/SpoT homolog protein, which is involved
in the synthesis and degradation of guanosine tetrapho-
sphate (ppGpp). In bacteria, ppGpp is a stringent-response
mediator that coordinates cellular activities in response
to changes in nutrient abundance [14,15]. We therefore
tested the effects of variation in other genes involved in
the stringent response pathway using, once again, naturally
existing genomic diversity. Interestingly, evidence sug-
gested that variation in another RelA/SpoT homolog pro-
tein encoded by the gene with TIGR4 locus tag is also
associated with change in resistance to neutrophil-killing.
Construction and testing isogenic strains further con-
firmed the causal effects of the SNP in the gene with
TIGR4 locus tag SP_1097. These data suggested that RelA/
SpoT homolog proteins in pneumococcus could play a
critical role in regulating bacterial responses to neutrophil-
killing. Interestingly, no significant difference in competi-
tiveness against SpnYL049 observed between SpnYL106
and SpnYL107 in the mouse colonization experiment
(Additional file 1: Figure S2). The results indicated that,
consistent with previous studies [4,5], resistance to phago-
cytic killing is an important but not the only mechanism to
regulate pneumococcal colonization ability. It should be
noted that mouse colonization in vivo and surface phago-
cytosis killing in vitro are two complementary, relevant, if
imperfect model systems we used to understand the
pneumococcal determinants of colonization success in hu-
man populations. More studies using a variety of ap-
proaches are needed to dissect the possible links between
activities of GTP pyrophosphokinase (including gene prod-
ucts of SP_1645 and SP_1097), levels of stringent response,
and pneumococcal colonization success.
The increasing availability of large, publicly available
genomic datasets, combined with relatively inexpensive
sequencing of laboratory variants, provides a wealth of in-
formation that can be mined for polymorphisms with in-
teresting phenotypic consequences. In addition to whole
genome sequences, databases on transcriptomics, proteo-
mics, protein structure, and specific functions (e.g. anti-
biotic resistance, immunogenicity) could also be mined to
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obtain information on potential role of the targets, and
therefore help focusing on genetic variations of high likeli-
hood of functional consequences. The approach used here
requires access to enable us to search such data for suit-
ably matched, closely related isolates distinguished by the
polymorphism of interest, and then to the selected isolates
themselves for phenotypic evaluation. In this study we
used carriage isolates to which we already had access and
their whole genome sequences, which are not trivial to ob-
tain. In order to facilitate more general use at the public
level, affordable publicly funded repositories (e.g. the BEI
resources http://www.beiresources.org/) should be sup-
ported. The option to use an in silico search of genomic
sequence database to identify comparable isolates in which
the SNP has already occurred in the course natural evolu-
tion can be far more efficient than constructing an iso-
genic mutant in vitro. This method allows us to quickly
screen multiple SNPs and narrow down a candidate list to
those with high likelihood of causing a phenotypic differ-
ence. The same procedure can be applied to studying the
effect of genetic variation in other microorganisms for
which collections of diverse isolates and their full-genome
sequences are available. It will be particularly useful when
gene replacement and creation of isogenic strains are diffi-
cult to achieve, such as in studies of essential genes or mi-
croorganisms with low recombination rate. Given the fast
growing database of whole genome sequencing data for
many different organisms [16,17], a method that uses nat-
urally existing diversity of microbial populations to accel-
erate gene function analysis could be increasingly feasible
for a wide range of microorganisms. In addition, as these
databases grow the chance of sampling closely related iso-
lates that differ at the locus of interest will grow with
them. To the extent isolates (or phenotypic measurements
thereof) are available with genomic sequences, it will then
be possible to go one step further, evaluating the extent to
which genetic differences experimentally proven to cause
phenotypic traits in laboratory strains are correlated with
these traits in natural populations, where genetic back-
grounds will be more variable. Analogous to testing animal
model results in human populations by epidemiological
studies, such surveys of natural genetic and phenotypic
variation will provide a much fuller picture of the signifi-
cance of laboratory findings.
Conclusions
A single nucleotide change in pneumococcal RelA/ SpoT
homolog involved in the stringent response (GTP pyro-
phosphokinase, TIGR4 locus tag SP_1645) was identified
to reduce the ability of pneumococcus to compete for
colonization and decrease the resistance to killing by hu-
man neutrophils. The identification process was shown to
benefit from a strategy that includes analyzing 616 previ-
ously published pneumococcal genome sequences to select
closely-related strains carrying genetic variation of interest
for phenotypic evaluation. The utility of this strategy was
additionaly demonstrated by identifing variation in another
RelA/ SpoT homolog (TIGR4 locus tag SP_1097) that
causes change in resistance to neutrophil-killing. We con-
clude that analysis of naturally occurring genome diversity
can be used to complement traditional genetics ap-
proaches to accelerate the genotype-phenotype analysis.
Methods
Ethics statement
Human blood was obtained from healthy adult volun-
teers according to a protocol approved by the Office of
Human Research Administration at Harvard School of
Public Health (protocol number CR-10199-04). All adult
subjects provided informed consent in written.
All animal work has been conducted in compliance
with the Animal Welfare Act and the guidelines of the
U.S. Public Health Service Policy on Humane Care and
Use of Laboratory Animals, and specifically approved
by the Institutional Animal Care and Use Committee
(IACUC) of Harvard Medical School (protocol number
2991; Animal Welfare Assurance of Compliance A3431-
01 and AAALAC Accreditation #000009, 6/12/13). Mice
were euthanized via CO2 inhalation followed by bilateral
thoracotomy.
Strains, cells, and animals
Six capsular variants of the TIGR4 strain (TIGR4:1,
TIGR4:4, TIGR4:14, TIGR4:19A, TIGR4:19F, and
TIGR4:23F) were constructed and reported previously [4].
The SpnYL101 strain is a laboratory variant of the
TIGR4:19F strain, which arose during subcultures of the
TIGR4:19F strain. To construct the SpnYL102 and the
SpnYL103 strains, the SP_1645 locus in the TIGR4:19F
and SpnYL101 was replaced with a Janus-type cassette
[17] by using the transformation protocol described previ-
ously [18,19]. The Janus cassette in the SpnYL102 strain
was then replaced by the allele corresponding to SP_1645
sequence in SpnYL101 to create the SpnYL104 strain.
Similarly, the Janus cassette in the SpnYL103 strain was
then replaced by the SP_1645 sequence amplified from
the TIGR4:19F genomic DNA by PCR to create the
SpnYL105 strain.
To construct the SpnYL106 strain, the upstream se-
quence of the SP_1097 locus (TIGR4 reference genome
position 1029105–1030387), the kanamycin-resistance
marker, the allele sequence corresponding to SP_1097 in
isolate 135771 (including 109-bp upstream of the start
codon), and the downstream sequence of the SP_1097
locus (TIGR4 reference genome position 1031171–
1032329) were amplified by PCR and the PCR products
were ligated in that order by using the Gibson Assembly
Kit (New England BioLabs, Ipswich, MA). The assembly
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product was used to transform TIGR4:6B with selection for
kanamycin resistance. After transformation, the SP_1097
locus was amplified by PCR from 12 kanamycin-resistant
clones and the PCR products were sequenced to identify
clones with correct allele sequence corresponding to
SP_1097 in isolate 135771. The same strategy was used to
construct the SpnYL107 strain.
Nasopharyngeal carriage isolates were colony-purified
prior to use. All strains were grown in Todd Hewitt Broth
with 0.5% yeast extract (THY) (BD, Franklin Lakes, NJ) at
37°C with 5% CO2. Strains and PCR primers used in this
study are listed in Additional file 1: Table S3.
Neutrophils were isolated from human blood using
Histopaque 10771, 11191 gradient reagents (Sigma-
Aldrich, St. Louis, MO) according to the manufac-
turer’s instructions and used immediately.
Wild-type C57BL/6 mice were obtained from the Jackson
ImmunoResearch Laboratories, Bar Harbor, ME. All mice
were female, 9 to 10 weeks old at the start of experiments,
and were kept in a BSL2 facility.
Bacterial growth rate
Strains were streaked onto blood agar plates and cultured
at 37°C in 5% CO2 overnight. Twelve colonies from each
strain were subcultured in Todd–Hewitt medium with
0.5% yeast extract (THY; Becton Dickinson and Company,
Sparks, MD) until O.D. 620 reached ~ 0.4 and then diluted
into THY medium at a starting culture O.D. of ~0.005.
Growth was monitored in sterile flat-bottomed 96-well
microtitre plates (Nunc, Denmark) containing 200 μl cul-
ture each well every 30 minutes using a VERSAmax mi-
croplate reader (Molecular Devices, Sunnyvale, CA) over
6 hours. The growth curves were fitted to an exponential
growth equation and the growth rate was estimated using
Graphpad Prism software (GraphPad Software, Inc., CA).
Mouse carriage model and competitive index
quantification
In the single-strain colonization experiment, C57BL/6
mice (n = 5 for each group) were inoculated intranasally
with in 10 μl of PBS containing approximately 1 ×
107 CFU of either TIGR4:19F or SpnYL101. After inocu-
lation, nasal wash samples were collected on day 1 by
live sampling and on day 4 by post-mortem tracheal
wash as previously described [13]. Aliquots of each sam-
ple were titered on gentamicin plate (2.5 mg/L) to deter-
mine the colony forming unit (CFU) density.
The multi-strain pneumococcal colonization experi-
ments were performed essentially as previously described
[20]. In 6-strain colonization experiments, five TIGR4 cap-
sular variants (TIGR4:1, TIGR4:4, TIGR4:14, TIGR4:19A,
TIGR4:23F) were mixed with either TIGR4:19F or
SpnYL101 at equal ratio. C57BL/6 mice were inoculated
intranasally with the mixtures in 10 μl of PBS containing
approximately 1 × 106 CFU of each strain. In 2-strain
colonization experiments, a reference strain (TIGR4:19A)
was mixed with either SpnYL104 or SpnYL105 at equal
ratio. C57BL/6 mice were inoculated intranasally with the
mixtures in 10 μl of PBS containing approximately 5 ×
106 CFU of each strain. Nasal wash samples were collected
up to 7 days after challenge as previously described [13].
Aliquots of each sample were titered to determine the col-
ony forming unit (CFU) density in sample. The remaining
samples were cultured overnight on blood agar plates sup-
plemented with gentamicin to a final concentration of
2.5 mg/L, and all bacterial growth was harvested for gen-
omic DNA extraction.
Genomic DNA was purified from cultures of samples
collected from animals using DNeasy Blood and Tissue
kit (QIAGEN, Valencia, CA). The relative abundance of
each strain in a sample was determined by a relative
quantification protocol of the 7300 Real Time PCR
System (Applied Biosystems). Serotype-specific primers
were adopted from a previous study [21] and are listed
in Additional file 1: Table S3. The calibrator was com-
posed of 6 types of genomic DNA (TIGR4:1, TIGR4:4,
TIGR4:14, TIGR4:19A, TIGR4:19F, and TIGR4:23F) with
equal concentration (0.25 ng/μl each). The DNA se-
quence specifically amplified by primers 19 F-forward
and 19 F-reverse was used as the endogenous control
while DNA sequences amplified by other serotype-
specific primers were treated as targets. Total reaction
volume of 25 μl was composed of 1 × SYBR GREEN
PCR Master Mix (Applied Biosystems), 2 ng of genomic
DNA and 400 nM of each primer. Two replicates reac-
tions for each sample and the calibrator were performed.
The relative level of each target in a sample was calcu-
lated by the RQ Study software (Applied Biosystems) ac-
cording to manufacturer’s protocol. The frequency of
the TIGR4:19F or SpnYL101 specific DNA in a sample
was calculated as 1/(1+ the sum of all targets level). The
competitive index of a 19 F variant was calculated as A1-
A0, where A1 and A0 are the log10 transformation of the
ratio of the 19 F specific DNA frequency to the (1-19 F
specific DNA frequency) in a nasal wash sample and in
the inoculation mixture, respectively. This relative quan-
tification method has been validated by using DNA sam-
ples of known composition (Additional file 1: Figure S3
and Table S4). According to the validation, we set 3
and −3 as the high and low detection limits for the
competitive index, respectively. Calculated competitive
index values beyond the limit of detection were rounded
to the nearest limit value.
Competitive indexes for strains SpnYL106 and SpnYL107
were measured against a reference strain of the same sero-
type but distinct antibiotic resistance. The reference strain,
SpnYL049 (serotype 6B, Kanamycin sensitive (Kans) and
Trimethoprim resistant (Trir)), was mixed with either
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SpnYL106 (serotype 6B KanrTris) or SpnYL107 (serotype
6B, Kanr Tris) at equal ratio. C57BL/6 mice (n = 10 for each
group) were inoculated intranasally with the mixtures in
10 μl of PBS containing approximately 5 × 106 CFU of each
strain. After inoculation, nasal wash samples were collected
on day 1 by live sampling and on day 4 by post-mortem
tracheal wash as previously described [13]. Aliquots of each
sample were titered on two types of blood agar plates:
Tri plate (containing 3.2 mg/mL Trimethoprim and
2.5 mg/L gentamicin) and Kan plate (containing
500 mg/L Kanamycin). Titer below the detection limit
was denoted as one-half on the detection limit. For each
sample in which at least one strain was detectable, the
competitive index was calculated as: log10(Kan
r CFU
density/Trir CFU density) in the sample - log10(Kan
r CFU
density/Trir CFU density) in the inoculation mixture.
Neutrophil surface killing assay
Neutrophil surface killing assays were performed as de-
scribed previously [4]. Briefly, bacteria were grown to mid-
log phase and frozen in THY/10% glycerol at −80°C. On
the day of the experiment, bacteria were thawed and
diluted to 5 × 103 CFU/mL in saline, and 10 μL of this
suspension was spotted and allowed to dry at room
temperature on trypticase soy agar with 5% defibrinated
sheep blood, with 10 replicates per plate. Twenty microli-
ters of neutrophils (2 × 106 cells/mL) were then overlaid,
allowed to dry, and incubated overnight at 37°C with 5%
CO2. Percent survival was calculated by comparing killing
of each strain to a duplicate control plate with no
neutrophils.
Whole-genome sequencing
Genomic DNA from isolates TIGR4:19F and SpnYL101
were used to generate multiplexed Illumina libraries
using Nextera DNA sample preparation kits. These were
sequenced on the Illumina MiSeq platform to produce
151 nt paired-end reads, generating a total of 213,083
reads (64.4 Mb of data) for TIGR4:19F and 383,055
reads (115.7 Mb of data) for SpnYL101. This equates to
over 30-fold and over 50-fold mean coverage of a typical
pneumococcal genome, respectively. Illumina sequence
data were mapped against the complete genome of S.
pneumoniae TIGR4 (GenBank accession: AE005672) as
paired end reads using SMALT v0.6.1. Bases were called
using Samtools [22] and VCFtools [23] using the criteria
described previously [24]. These sequence data have
been submitted to the Sequence Read Archive (SRA)
with accession number SRX535517.
In silico screen of carriage isolates
The collection of carriage isolates used in this study cor-
respond to 616 de novo assemblies of asymptomatically
carried S. pneumoniae isolates, in which 5,442 clusters
of orthologous genes (COGs) were identified and were
previously reported [9]. BLASTP was used to identify
the COG corresponding to each TIGR4 gene that is af-
fected by SNPs between TIGR4:19F and SpnYL101. To
identify an isolate pair varied substantially at the target
gene, coding sequences in the COG were aligned by
CLUSTAL 2.1 [25]. After alignment, two sequences
showed the least percent identity at the target gene and
belonged to isolates of the same serotype were chosen to
form a pair. In case of a tie (two or more serotype-
matched pairs with equally low within-pair sequence
identity), the pair that represents the closest relatives, as
ascertained through the shortest phylogenetic distance
calculated from a whole genome alignment [9], was used
in subsequent phenotypic evaluations. A flowchart of the
porecess is shown in Additional file 1: Figure S4.
Polysaccharide quantification
Cell-associated type 19 F capsular polysaccharide was
quantified based on a previously published inhibition
ELISA protocol [4,26]. Briefly, immunolon ELISA plates
(Thermo Scientific, Waltham, MA) were coated by incu-
bating with 5 μg/mL type 19 F capsular polysaccharide
(ATCC, Manassas, VA; 100 μL/well) overnight. Either
standard dilutions of type 19 F polysaccharide or serial
dilutions of mid-log phase bacteria were mixed 1:1 with
typing serum 19b (Statens, 1:5000–1:10,000). The mix-
tures were incubated in the coated ELISA plates for two
hours. Typing sera captured by the coated plates were de-
tected with goat anti-rabbit IgG-HRP (Pierce, 1:60,000) and
the TMB developing substrate (KPL, Gaithersburg, MD).
After developing was terminated by addition of 1 N HCl,
the absorbance at 450 nm was measured using a VERSA-
max microplate reader (Molecular Devices, Sunnyvale,
CA). The software accompanied the microplate reader
was used to calculate the capsular polysaccharide con-
centration in each sample by a standard-curve method
(4-parameter fit).
Selection of putitative pneumococcal SR pathway genes
To select a pneumococcal gene putatively corresponding
to Lon in the SR pathway, a text search of “PDZ
domain-containing protein” in KEGG ORTHOLOGY
(http://www.genome.jp/kegg/) identified orthologous group
K07177, from which the only gene found in S. pneumoniae
TIGR4 strain, SP_1967, was chosen. Similarly, to select a
pneumococcal gene putatively corresponding to rpoS in
the SR pathway, a text search of “RNA polymerase primary
factor” in KEGG ORTHOLOGY identified orthologous
group K03086, from which the only gene found in S.
pneumoniae TIGR4 strain, SP_1073, was chosen. To select
a pneumococcal gene putatively corresponding to spoT in
the SR pathway, a text search of “putative GTP pyropho-
sphokinase” in KEGG ORTHOLOGY identified orthologous
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group K03086, from which the only gene found in S.
pneumoniaeTIGR4 strain, SP_1073, was chosen.
Statistics
Competitive index between two strains was compared
using a Mann–Whitney test. Survival rate, growth rate,
or capsular polysaccharide production between two
strains was compared using a t-test. All p-values were
calculated for two-tailed tests and p < 0.05 was consid-
ered as significant. Statistical analyses were conducted
using the GraphPad Prism V5.0 software (GraphPad
Software, San Diego, CA, USA) and the R software pack-
age (http://www.r-project.org/).
Additional file
Additional file 1: Figure S1. Growth rate of TIGR4:19F and the
SpnYL101. The strains were cultured in THY medium at 37°C with initial
O.D. 620 around 0.005, and the increase in O.D. 620 were measured for
2 hours. The increase in O.D. was fitted to an exponential growth to
estimate the growth rate. Error bars represent 95% CI. The p-value is
derived from t-test (n = 12 for each group). Figure S2. Competitive
indexes of strains SpnYL106 and SpnYL107 during mouse colonization were
measured against a reference strain SpnYL049, as described in Materials
and Methods. Competitive indexes derived from mousse nasal wash
samples in which at least one strain was detectable are shown. Horizontal
bars are medians. p-values are derived from Mann–Whitney tests. Figure S3.
Validation of the relative quantification assay. A sample was prepared by
mixing 6 types of genomic DNA at varied amount to a final total DNA
concentration of 2 ng/μl. The input frequency represents the relative
abundance of each type of DNA in a sample. The sample was analyzed by
the relative quantification assay as described in the Materials and Methods.
A linear relationship between the input frequency and the measured
frequency is shown. Each dot represents the result of a serotype form the
indicated input frequency. The dashed line represents the regression line.
Data from 4 independent samples are shown (see Table S4 for detailed
data). Slope and goodness of fit (R2) of the regression line are shown.
Figure S4. Flowchart of the process to identify an isolate pair from a
collection of isolates. Table S1. Pair wise strain distance derived from previously
published data. Table S2. Distribution of identified SNPs in a collection of
carriage isolates. Table S3. Bacterial strains and primers used in this study.
Table S4. Validation of the relative quantification assay.
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